Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026

Key Takeaway: Viatris Inc. has announced that it will report its third-quarter 2026 financial results on November 5, 2026. The company will host a conference call and live webcast at 8:30 a.m. ET to discuss these results. Investors and the public can access the live event through the company's investor website or by phone.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is set to report its financial results, indicating ongoing business activity.
  • The company is engaging with investors through a conference call and webcast.
  • Viatris emphasizes its mission to empower healthier lives globally.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 13 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 2 Diabetes

Full Press Release Details

PITTSBURGH, Oct. 5, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report third-quarter 2026 financial results on Thursday, November 5, 2026. Company executives will host a conference call and live webcast at 8:30 a.m. ET on the same date to discuss results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris report its Q3 2026 financial results?

Viatris will report its Q3 2026 financial results on November 5, 2026.

How can I listen to the Viatris earnings call?

You can listen to the Viatris earnings call via a live webcast or by phone.

What time is the Viatris conference call scheduled?

The Viatris conference call is scheduled for 8:30 a.m. ET.

Is there a replay available for the Viatris webcast?

Yes, a replay of the webcast will be available on the Viatris website.

Last updated: Oct 5, 2026